Cold plasma treatment for biomedical applications: using aluminum foam to reduce risk while increasing efficacy

Abstract

Plasma medicine is an emerging and innovative interdisciplinary research field combining biology, chemistry, physics, engineering, and medicine. However, the safe clinical application of cold atmospheric plasma (CAP) technology is still a challenge. Here, we examine the use of aluminum (Al) foam with three pores-per-inch (PPI) ratings in clinical plasma applications. Al foams can filter sparks to avoid damage from high voltage discharge during surgery and efficiently deliver reactive species generated in CAP to the target. The sparks appear and plasma intensity increases at the foam/discharge interface, which just slightly increases the interface temperature without changing the interface microstructure during a 30-minute treatment. After CAP penetrated the Al foams, N2, N2+, *OH, O, and He emission peaks were characterized, and the highest values appeared using Al foams with 10 PPI. CAP with and without Al foam intermediating was used to treat deionized water, and the results indicate CAP in combination with 10 PPI Al foam led to much higher ROS concentration than CAP alone. For melanoma cell experiments, CAP with and without Al foam had a similar effect on cell viability after 30-second treatment, while CAP with the 10-PPI Al foam had much higher killing efficiency than CAP alone after 60-second treatment. In summary, 10-PPI Al foam can not only prevent damage to tissues resulting from high discharge voltage during clinical surgery but also increase the delivery efficiency of reactive species generated in plasma for biomedical applications.